Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive examination. Proponents often highlight the potential for significant therapeutic outcomes, particularly in diseases where conventional medications have proven ineffective. However, crucially important to evaluate the significant financial investment associated wit